ANRESIS was developed between 2000 and 2004 as a part of the National Research Program 49 “Antibiotic Resistance” of the Swiss National Science Foundation under the lead of Professor Kathrin Mühlemann. In 2004 Professor Giorgio Zanetti implemented the antibiotic consumption database into ANRESIS. Resistance data from veterinary medicine were integrated for the first time in 2012 and since 2016 ANRESIS also contains data on human Clostridium difficile infections. The accessibility of ANRESIS via mobile devices was considerably simplified in 2018 with the introduction of the infect.info app.
ANRESIS was financially supported by the Swiss National Science Foundation until 2007. Between 2008 and 2015 it was co-financed by the Swiss Federal Office of Public Health (FOPH), the Conference of Cantonal Health Directors and the University of Bern. Since 2016 ANRESIS is co-financed by the FOPH and the Institute for Infectious Diseases (IFIK) of the University of Bern, which leads ANRESIS on behalf of the FOPH.
INterface For Empirical antimicrobial ChemoTherapy
An INterface For Empirical antimicrobial ChemoTherapy aims at assisting health professionals by providing intuitive access to the latest antimicrobial resistance data and swiss national guidelines.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.